For TOX, the expression followed the pattern AML-M2 > AML-M5 > AML-M3 (AML-M2 vs. AML-M5: P = 0.388; AML-M3 vs. AML-M5: P = 0.074; AML-M2 vs. AML-M3: P = 0.042). This evidence concerns the gene TOX and acute myeloid leukemia.